Showing results (191-200 of 635) with videos related to

Sort By:
Pageof 64
Cancer Medicine|August 30, 2022
Association of raloxifene and tamoxifen therapy with cognitive performance, odds of mild cognitive impairment, and brain MRI markers of neurodegenerationFirat Kara, Christine M Lohse, Anna M Castillo, et al.
International Journal of Cancer|October 16, 2007
Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell lineMassimiliano Cariati, Ali Naderi, John P Brown, et al.
ARYA Atherosclerosis|May 12, 2012
Effect of CRP on Some of the in vitro Physicochemical Properties of LDLHashem Nayeri, Gholam Ali Naderi, Masoud Saleh Moghadam, et al.
JAMA Oncology|May 27, 2021
Comparison of the Prevalence of Pathogenic Variants in Cancer Susceptibility Genes in Black Women and Non-Hispanic White Women With Breast Cancer in the United StatesSusan M Domchek, Song Yao, Fei Chen, et al.
Human Mutation|October 13, 2011
ENIGMA--evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genesAmanda B Spurdle, Sue Healey, Andrew Devereau, et al.
Scientific Reports|September 28, 2022
Assessment of small in-frame indels and C-terminal nonsense variants of BRCA1 using a validated functional assayThales C Nepomuceno, Ana P P Dos Santos, Vanessa C Fernandes, et al.
Briefings in Bioinformatics|September 12, 2015
Collaborative science in the next-generation sequencing era: a viewpoint on how to combine exome sequencing data across sites to identify novel disease susceptibility genesSteven N Hart, Kara N Maxwell, Tinu Thomas, et al.
Frontiers in Oncology|September 18, 2015
Disseminated Medulloblastoma in a Child with Germline BRCA2 6174delT Mutation and without Fanconi AnemiaJingying Xu, Ashley Sloane Margol, Anju Shukla, et al.
BMJ Open|October 27, 2021
Molecular markers of risk of subsequent invasive breast cancer in women with ductal carcinoma in situ: protocol for a population-based cohort studyThomas E Rohan, Mindy Ginsberg, Yihong Wang, et al.
Gynecologic Oncology|June 2, 2026
Clinical relevance of transcriptome profiling for assessing prognosis, platinum insensitivity, and precision therapeutics in endometrial cancerJesus Gonzalez-Bosquet, Maryam Shahi, Siddhartha Yadav, et al.
Pageof 64